ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance
Authors
Keywords
-
Journal
Gastroenterology Research and Practice
Volume 2018, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2018-02-02
DOI
10.1155/2018/3842198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Progress in the Earlier Detection of Pancreatic Cancer
- (2016) Teresa A. Brentnall JOURNAL OF CLINICAL ONCOLOGY
- Rapid quantitation of human epididymis protein 4 in human serum by amplified luminescent proximity homogeneous immunoassay (AlphaLISA)
- (2016) Hui Zhao et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Pancreatic Cancer Chemoprevention Translational Workshop
- (2016) Mark Steven Miller et al. PANCREAS
- Early Detection of Sporadic Pancreatic Cancer
- (2015) Suresh T. Chari et al. PANCREAS
- Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells
- (2015) Moitza Principe et al. Oncotarget
- Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest
- (2015) Michela Capello et al. Oncotarget
- Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma
- (2014) Ye Song et al. Molecular Cancer
- Development of an amplified luminescent proximity homogeneous assay for quantitative determination of hepatitis B surface antigen in human serum
- (2013) Tian-Cai Liu et al. CLINICA CHIMICA ACTA
- Vaccination With ENO1 DNA Prolongs Survival of Genetically Engineered Mice With Pancreatic Cancer
- (2013) Paola Cappello et al. GASTROENTEROLOGY
- Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target
- (2013) Kuan-Chung Hsiao et al. PLoS One
- RETRACTED: Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma
- (2012) Ponlapat Yonglitthipagon et al. CLINICAL BIOCHEMISTRY
- Potential tumor markers of renal cell carcinoma: α-Enolase for postoperative follow up, and galectin-1 and galectin-3 for primary detection
- (2012) Naoki Kaneko et al. INTERNATIONAL JOURNAL OF UROLOGY
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
- (2011) Sophia Y. Lunt et al. Annual Review of Cell and Developmental Biology
- The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma
- (2011) Sundeep Singh et al. DIGESTIVE DISEASES AND SCIENCES
- α-enolase: a promising therapeutic and diagnostic tumor target
- (2011) Michela Capello et al. FEBS Journal
- CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer
- (2011) Victor Molina et al. TUMOR BIOLOGY
- Proteomic analysis of pancreatic intraepithelial neoplasia and pancreatic carcinoma in rat models
- (2011) Lei Wang WORLD JOURNAL OF GASTROENTEROLOGY
- ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction
- (2010) Sen-Tien Tsai et al. EUROPEAN JOURNAL OF CANCER
- Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells
- (2009) Shih-Hsin Tu et al. BREAST CANCER RESEARCH AND TREATMENT
- An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen
- (2009) Paola Cappello et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started